Incretin-mediated control of cardiac energy metabolism.

Authors: Chan, Jordan S. F.^1,2,3, Shafaati, Tanin^1,2,3, Ussher, John R.^1,2,3 jussher@ualberta.ca

Source: Journal of Endocrinology. Oct2024, Vol. 263 Issue 1, p1-10. 10p.

Subject Terms: *GLUCAGON-like peptide 1, *GLUCAGON-like peptide-1 receptor, *MAJOR adverse cardiovascular events, *HEART metabolism, *GLYCEMIC control

Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy.

Authors: Shafaati, Tanin, Gopal, Keshav

Source: Journal of Pharmacy & Pharmaceutical Sciences; 2024, p1-9, 9p

Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy

Authors: Chan, Jordan S.F. ^{1, 2, 3, 12}, Tabatabaei Dakhili, Seyed Amirhossein ^{1, 2, 3, 12}, Lorenzana-Carrillo, Maria Areli ^{3, 4}, Gopal, Keshav ^{1, 2, 3}, Pulente, Serena M. ^{5, 6}, Greenwell, Amanda A. ^{1, 2, 3}, Yang, Kunyan ^{1, 2, 3}, Saed, Christina T. ^{1, 2, 3}, Stenlund, Magnus J. ^{1, 2, 3}, Ferrari, Sally R. ^{1, 2, 3}, Mangra-Bala, Indiresh A. ^{1, 2, 3}, Shafaati, Tanin ^{1, 2, 3}, Bhat, Rakesh K. ⁷, Eaton, Farah ^{1, 2, 3}, Overduin, Michael ⁷, Jørgensen, Sebastian Beck ⁸, Steinberg, Gregory R. ^{9, 10, 11}, Mulvihill, Erin E. ^{5, 6}, Sutendra, Gopinath ^{3, 4}, Ussher, John R. ^{1, 2, 3, 13, ∗}

Source: In Cell Reports 27 August 2024 43(8)